ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

GOVX GeoVax Labs Inc

1.61
0.19 (13.38%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
GeoVax Labs Inc GOVX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.19 13.38% 1.61 14:00:05
Open Price Low Price High Price Close Price Previous Close
1.42 1.42 1.70 1.61 1.42
more quote information »

Recent News

Date Time Source Heading
05/4/202403:30GLOBEGeoVax Presents Data on GEO-CM04S1, a Next Generation..
29/3/202400:00GLOBEGeoVax to Present Data on GEO-CM04S1, a Next Generation..
13/3/202400:00GLOBEGeoVax to Present at the 36th Annual Roth Conference
12/3/202407:13EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
11/3/202415:15EDGAR2Form EFFECT - Notice of Effectiveness
07/3/202401:00GLOBEGeoVax Achieves Milestone in Transition to Commercially..
02/3/202408:08EDGAR2Form S-3 - Registration statement under Securities Act of..
01/3/202408:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/3/202408:00GLOBEGeoVax Reports 2023 Year-End Financial Results and Provides..
23/2/202408:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202401:00GLOBEGeoVax to Report 2023 Financial Results and Provide..
20/2/202401:00GLOBEGeoVax to Present at the 2024 BIO CEO & Investor Conference
17/2/202408:01EDGAR2Form 8-K - Current report
15/2/202407:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202401:00GLOBEGeoVax Announces Multiple Patent Issuances and Allowances
08/2/202408:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202401:00GLOBEGeoVax Reports Positive Interim Data From Phase 2 Clinical..
01/2/202405:13EDGAR2Form 8-K - Current report
30/1/202401:00GLOBEGeoVax Announces 1-for-15 Reverse Stock Split to Regain..
17/1/202408:03EDGAR2Form 8-K - Current report
13/1/202408:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/1/202401:00GLOBEGeoVax Appoints Dr. Marc Pipas as Executive Medical..
05/1/202401:00GLOBEGeoVax Announces Gedeptin® Patient Enrollment Closure for..
04/1/202401:00GLOBEGeoVax Announces Issuance of Malaria Vaccine Patent
03/1/202408:10EDGAR2Form S-1 - General form for registration of securities under..
28/12/202301:00GLOBEGeoVax to Present at Biotech Showcase During J.P. Morgan..
27/12/202307:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202301:00GLOBEGeoVax Expands Rights Under NIH COVID-19 License to Include..
09/12/202308:02EDGAR2Form 8-K - Current report
05/12/202300:00EDGAR2Form 8-K - Current report
01/12/202308:30GLOBEGeoVax Hemorrhagic Fever Vaccine Data Presented at World..
30/11/202301:00GLOBEGeoVax to Participate in Upcoming December Investor Events
29/11/202301:00GLOBEGeoVax COVID-19 Vaccine Clinical Data Presented at World..
28/11/202308:06EDGAR2Form DEF 14A - Other definitive proxy statements
18/11/202308:27EDGAR2Form PRE 14A - Other preliminary proxy statements
15/11/202301:00GLOBEProgress on GeoVax’s Universal Coronavirus Vaccine..
10/11/202304:40EDGAR2Form 8-K - Current report
09/11/202308:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/11/202308:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/11/202308:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/11/202308:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202308:00GLOBEGeoVax Reports Third Quarter 2023 Financial Results and..
01/11/202300:00GLOBEGeoVax to Report Third Quarter 2023 Financial Results and..
31/10/202300:00GLOBEGeoVax Commences Site Expansion for Phase 2 Trial of..
26/10/202300:00GLOBEGeoVax to Participate in Upcoming November Investor and..
25/10/202300:00GLOBEGeoVax Update: Clinical and Operational Progress Toward..
10/10/202300:00GLOBEGeoVax Receives Notice of Allowance for Marburg Vaccine..
06/10/202300:00GLOBEGeoVax Receives Notice of Allowance for HIV Vaccine Patent
28/9/202306:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202323:00GLOBEGeoVax to Participate in Upcoming October Investor and..

Your Recent History

Delayed Upgrade Clock